About
Beauteeze.com is a new online platform that streamlines, simplifies, and reduces the hassle of personal beauty care by allowing users to search and schedule personal beauty appointments all via one central site. The spas and salons that are our clients benefit by showcasing their services online, allowing them to expand their customer base, offer tailored deals, fill-in last minute openings, and compile a comprehensive database of customers. The individuals who are our customers benefit by increased selection, filtered results by price, location and treatments, ease of use, and exclusive deals and offers. For every appointment scheduled, we will donate $.50 to NY-based charity SHARE. SHARE helps people through breast or ovarian cancer with educational programs, support groups, and public-health initiatives.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the primary function of Beauteeze?
- Beauteeze is an online platform designed to simplify and streamline the process of searching for and scheduling personal beauty appointments.
- When was Beauteeze founded?
- Beauteeze was founded in January 2012.
- What is the operational status of Beauteeze?
- Beauteeze has been inactive since August 2013.
- Where is Beauteeze's headquarters located?
- Beauteeze's headquarters is located at 10 W 18th St, New York, NY 10023, in the United States.
- What business model does Beauteeze primarily use?
- Beauteeze operates on a B2B2C business model, serving both beauty businesses (spas and salons) and individual consumers.
- Who are the founders of Beauteeze?
- The founders of Beauteeze are Abigail Ziff and Adi Turgeman.
- What is Beauteeze's current funding stage?
- Beauteeze is currently in the Pre-Funding stage, with a total of $0 raised in USD.
- What charitable initiative did Beauteeze support?
- For every appointment scheduled through its platform, Beauteeze pledged to donate $0.50 to SHARE, a NY-based charity supporting people with breast or ovarian cancer.